Objectives: The document aims to study the relations between psychosocial environment and health risk behaviors (cigarette smoking, alcohol consumption, drunkenness, perpetration of intimidation and early start of sex life) in a representative sample of Bulgarian teenagers .
Methods: We apply multilevel analysis, using Bulgarian health behavior data 2017/2018 in the study of school age children (HBSC).
Results: There is a significant variation between the schools of Bulgaria in the proportions of students who smoke cigarettes, drink alcohol, are drunk and have an early start of sex life. The satisfaction of the lower school is considerably associated with chances of smoking and higher drunkenness. The effect of the pressure of the school differs for the perpetration of smoking and intimidation. The effect of student assistance also differs for certain types of health risk behaviors. The support of higher students is positively associated with frequent consumption of alcohol and drunkenness. The relationship between teacher support and alcohol abuse is negative.
Conclusions: There is an important association between the characteristics of the psychosocial school environment and the health behaviors of Bulgarian adolescents (smoking, alcohol consumption, intoxication, perpetration of intimidation). Global and efficient health promotion policies in Bulgarian schools are needed to facilitate healthy lifestyles. The most commonly heterogeneous and clinically heterogeneous carcinomas and the most common malignant tumor of the urinary tract in developed countries in the world, where several control point cubes as a ligand-1 programmed death (PD- L1) and programmed cell death proteins (PD- 1) received the most attention in the treatment of bladder cancer. However, the clinical impact of this biomarker has not yet been established.
Contribution of metabolic syndrome components to cognitive performance in middle-aged adults
The metabolic syndrome (dishes) has been associated with altered cognition in different cognitive domains. This study investigated the association between diseases and the cognitive functioning of middle-aged Bubarians on different definitions of the severity of dishes. Our transverse sample included 112 participants (67 without briefcase and 45 with maletics) with an average age of 50.04 ± 3.31 years. The following method variables have been considered as the presence of dishes, permanently measured dishes, dichotomized dishes components, the number of dishes components present and the gravity score of metabolic syndrome (MSSS). The cognitive performance of the participants was evaluated using the consortium to establish a register of the neuropsychological battery of Alzheimer’s disease (CERAD-NB).
We used multivariate regression models to investigate associations between different measures of the severity of the dishes and total and CERAD-NB sub-test scores. On several definitions, the dishes have been associated with lower cognitive functioning and the severity of the bets appeared to be a better predictor than most components of the MET. Recognition and reduction of the severity of dishes components may be useful for supporting cognitive operation. Additional longitudinal research is needed to lose more light on the relationship between dishes and cognitive functioning throughout the life. This document includes a catalog of the type of genuine butterflies (papironoida) kept in the National Museum of Natural History at the Bulgarian Academy of Sofia Sciences.
The collection contains types of nine group taxa of nominal species, described by S. Abadjiev, S. Beshkov, I. Buresch, H. Rebel and K. Tuxchkow. The lectotypes have been designated for colias myrmidone Balcanica Rebel, 1901, Erebia Tyndarus Macedonica Buresch, 1919, E. Pirinica Buresch, 1919, Euchloe Gruneri Macedonica Buresch, 1921, Sathusa Strumata Buresch, 1919 and Dorite Apollinus Var. Thracica Buresch, 1915.

NMR profiling of North and Bulgarian Macedonian honeys for the detection of botanical and geographical origin
Bulgaria and North Macedonia have a long history of the production and use of honey; However, there is a clear lack of systematic and deepened research on honey from both countries. Honey oak honey is of particular interest because it is highly appreciated by consumers because of its health benefits. The objective of this study was to characterize honey and floral honey from Bulgaria and North Macedonia based on their NMR profiles. The 1D and 2D 1H and 13C-NMR spectra were measured by 16 North Macedonian honey samples and 22 Bulgarian honey samples.
In total, 25 individual substances have been identified, including quinovose, which was found for the first time at honey. Chemometric methods (PCA-main component analysis, pls-da-partial discriminating analysis, Anova-analysis of the variance) were used to detect the similarities and differences between samples, as well as to determine their botanical origin and geographical. Semicarative data on individual sugars and some other constituents have been obtained, which allowed the reliable classification of honey samples by botanical and geographical origin, based on chemometric approaches.
PRDM5 Polyclonal Antibody |
|||
A-2005 | EpiGentek |
|
|
PRDM10 Polyclonal Antibody |
|||
A-2010 | EpiGentek |
|
|
PRDM11 Polyclonal Antibody |
|||
A-2011 | EpiGentek |
|
|
PRDM13 Polyclonal Antibody |
|||
A-2013 | EpiGentek |
|
|
PRDM16 Polyclonal Antibody |
|||
A-2016 | EpiGentek |
|
|
PRDM17 Polyclonal Antibody |
|||
A-2017 | EpiGentek |
|
|
EZH1 Polyclonal Antibody |
|||
A-2018 | EpiGentek |
|
|
HSF1 Polyclonal Antibody |
|||
A-2401 | EpiGentek |
|
|
PRMT3 Polyclonal Antibody |
|||
A-3003 | EpiGentek |
|
|
SET1 Polyclonal Antibody |
|||
A-3011 | EpiGentek |
|
|
SET07 Polyclonal Antibody |
|||
A-3013 | EpiGentek |
|
|
LSD1 Polyclonal Antibody |
|||
A-3018 | EpiGentek |
|
|
HDAC10 Polyclonal Antibody |
|||
A-4010 | EpiGentek |
|
|
PCAF Polyclonal Antibody |
|||
A-4012 | EpiGentek |
|
|
Histone H3K9ac (Acetyl H3K9) Polyclonal Antibody |
|||
A-4022 | EpiGentek |
|
|
Histone H3K14ac (Acetyl H3K14) Polyclonal Antibody |
|||
A-4023 | EpiGentek |
|
|
Histone H3K18ac (Acetyl H3K18) Polyclonal Antibody |
|||
A-4024 | EpiGentek |
|
|
Histone H3K23ac (Acetyl H3K23) Polyclonal Antibody |
|||
A-4025 | EpiGentek |
|
|
Histone H3K56ac (Acetyl H3K56) Polyclonal Antibody |
|||
A-4026 | EpiGentek |
|
|
Histone H3K4me1 (H3K4 Monomethyl) Polyclonal Antibody |
|||
A-4031 | EpiGentek |
|
|
Histone H3K4me2 (H3K4 Dimethyl) Polyclonal Antibody |
|||
A-4032 | EpiGentek |
|
|
Histone H3K4me3 (H3K4 Trimethyl) Polyclonal Antibody |
|||
A-4033 | EpiGentek |
|
|
Histone H3K9me1 (H3K9 Monomethyl) Polyclonal Antibody |
|||
A-4034 | EpiGentek |
|
|
Histone H3K9me2 (H3K9 Dimethyl) Polyclonal Antibody |
|||
A-4035 | EpiGentek |
|
|
Histone H3K9me3 (H3K9 Trimethyl) Polyclonal Antibody |
|||
A-4036 | EpiGentek |
|
|
Histone H3K27me1 (H3K27 Monomethyl) Polyclonal Antibody |
|||
A-4037 | EpiGentek |
|
|
Histone H3K27me2 (H3K27 Dimethyl) Polyclonal Antibody |
|||
A-4038 | EpiGentek |
|
|
Histone H3K27me3 (H3K27 Trimethyl) Polyclonal Antibody |
|||
A-4039 | EpiGentek |
|
|
Histone H3K36me1 (H3K36 Monomethyl) Polyclonal Antibody |
|||
A-4040 | EpiGentek |
|
|
Histone H3K36me2 (H3K36 Dimethyl) Polyclonal Antibody |
|||
A-4041 | EpiGentek |
|
|
Histone H3K36me3 (H3K36 Trimethyl) Polyclonal Antibody |
|||
A-4042 | EpiGentek |
|
|
Histone H3K79me1 (H3K79 Monomethyl) Polyclonal Antibody |
|||
A-4043 | EpiGentek |
|
|
Histone H3K79me2 (H3K79 Dimethyl) Polyclonal Antibody |
|||
A-4044 | EpiGentek |
|
|
Histone H3K79me3 (H3K79 Trimethyl) Polyclonal Antibody |
|||
A-4045 | EpiGentek |
|
|
Histone H4K20me1 (H4K20 Monomethyl) Polyclonal Antibody |
|||
A-4046 | EpiGentek |
|
|
Histone H4K20me2 (H4K20 Dimethyl) Polyclonal Antibody |
|||
A-4047 | EpiGentek |
|
|
Histone H4K20me3 (H4K20 Trimethyl) Polyclonal Antibody |
|||
A-4048 | EpiGentek |
|
|
Histone H3K27ac (Acetyl H3K27) Polyclonal Antibody |
|||
A-4708 | EpiGentek |
|
|
CRISPR Cas9 Monoclonal Antibody [7A9] |
|||
A-9000 | EpiGentek |
|
|
CRISPR/Cas9 (SaCas9) Monoclonal Antibody [6H4] |
|||
A-9001 | EpiGentek |
|
|
CLIMP-63 Polyclonal Antibody |
|||
A-0701 | EpiGentek |
|
|
DNMT3A Polyclonal Antibody |
|||
A-1003 | EpiGentek |
|
|
DNMT3B Polyclonal Antibody |
|||
A-1004 | EpiGentek |
|
|
DNMT3L Polyclonal Antibody |
|||
A-1005 | EpiGentek |
|
|
MBD3 Polyclonal Antibody |
|||
A-1008 | EpiGentek |
|
|
MGMT Polyclonal Antibody |
|||
A-1010 | EpiGentek |
|
|
MeCP2 Polyclonal Antibody |
|||
A-1012 | EpiGentek |
|
|
TET1 Polyclonal Antibody |
|||
A-1020 | EpiGentek |
|
|
DNMT1 Polyclonal Antibody |
|||
A-1700 | EpiGentek |
|
|
TET2 Polyclonal Antibody |
|||
A-1701 | EpiGentek |
|
|
MBD2 Polyclonal Antibody |
|||
A-1713 | EpiGentek |
|
|
PRDM2 Polyclonal Antibody |
|||
A-2002 | EpiGentek |
|
|
PRDM3 Polyclonal Antibody |
|||
A-2003 | EpiGentek |
|
|
PRDM6 Polyclonal Antibody |
|||
A-2006 | EpiGentek |
|
|
PRDM12 Polyclonal Antibody |
|||
A-2012 | EpiGentek |
|
|
PRDM14 Polyclonal Antibody |
|||
A-2014 | EpiGentek |
|
|
EZH2 Polyclonal Antibody |
|||
A-2019 | EpiGentek |
|
|
EED Polyclonal Antibody |
|||
A-2020 | EpiGentek |
|
|
Swi2/SNF2 Polyclonal Antibody |
|||
A-2023 | EpiGentek |
|
|
SNFa/BRM Polyclonal Antibody |
|||
A-2025 | EpiGentek |
|
|
Ini1 Polyclonal Antibody |
|||
A-2026 | EpiGentek |
|
|
RNA Polymerase II Monoclonal Antibody [CTD4H8] |
|||
A-2032 | EpiGentek |
|
|
CBX5 Polyclonal Antibody |
|||
A-2701 | EpiGentek |
|
|
EGLN1 Polyclonal Antibody |
|||
A-2702 | EpiGentek |
|
|
RBBP4 Polyclonal Antibody |
|||
A-2703 | EpiGentek |
|
|
SIN3A Polyclonal Antibody |
|||
A-2704 | EpiGentek |
|
|
CTBP1 Polyclonal Antibody |
|||
A-2705 | EpiGentek |
|
|
PADI4 Polyclonal Antibody |
|||
A-2706 | EpiGentek |
|
|
SMARCA5 Polyclonal Antibody |
|||
A-2707 | EpiGentek |
|
|
IDH1 Polyclonal Antibody |
|||
A-2708 | EpiGentek |
|
|
CHD4 Polyclonal Antibody |
|||
A-2709 | EpiGentek |
|
|
CHAF1A Polyclonal Antibody |
|||
A-2710 | EpiGentek |
|
|
BRD7 Polyclonal Antibody |
|||
A-2712 | EpiGentek |
|
|
UHRF1 Polyclonal Antibody |
|||
A-2714 | EpiGentek |
|
|
UHRF2 Polyclonal Antibody |
|||
A-2715 | EpiGentek |
|
|
SMARCE1 Polyclonal Antibody |
|||
A-2716 | EpiGentek |
|
|
ACTL6A Polyclonal Antibody |
|||
A-2717 | EpiGentek |
|
|
MPG Polyclonal Antibody |
|||
A-2718 | EpiGentek |
|
|
HIF1AN Polyclonal Antibody |
|||
A-2719 | EpiGentek |
|
|
RNF2 Polyclonal Antibody |
|||
A-2720 | EpiGentek |
|
|
PCGF6 Polyclonal Antibody |
|||
A-2721 | EpiGentek |
|
|
SMARCB1 Polyclonal Antibody |
|||
A-2722 | EpiGentek |
|
|
ALKBH3 Polyclonal Antibody |
|||
A-2723 | EpiGentek |
|
|
BBOX1 Polyclonal Antibody |
|||
A-2724 | EpiGentek |
|
|
BTAF1 Polyclonal Antibody |
|||
A-2725 | EpiGentek |
|
|
CXXC1 Polyclonal Antibody |
|||
A-2726 | EpiGentek |
|
|
KDM4B Polyclonal Antibody |
|||
A-2727 | EpiGentek |
|
|
HELLS Polyclonal Antibody |
|||
A-2728 | EpiGentek |
|
|
ING3 Polyclonal Antibody |
|||
A-2729 | EpiGentek |
|
|
ING4 Polyclonal Antibody |
|||
A-2730 | EpiGentek |
|
|
PHC1 Polyclonal Antibody |
|||
A-2731 | EpiGentek |
|
|
SMARCAD1 Polyclonal Antibody |
|||
A-2732 | EpiGentek |
|
|
USP16 Polyclonal Antibody |
|||
A-2733 | EpiGentek |
|
|
SMARCC1 Polyclonal Antibody |
|||
A-2734 | EpiGentek |
|
|
ERCC6L Polyclonal Antibody |
|||
A-2735 | EpiGentek |
|
|
SMYD5 Polyclonal Antibody |
|||
A-2736 | EpiGentek |
|
|
ATF2 Polyclonal Antibody |
|||
A-2738 | EpiGentek |
|
|
BMI1 Polyclonal Antibody |
|||
A-2739 | EpiGentek |
|
|
CTBP2 Polyclonal Antibody |
|||
A-2740 | EpiGentek |
|
|
CTCF Polyclonal Antibody |
|||
A-2741 | EpiGentek |
|
|
MTA2 Polyclonal Antibody |
|||
A-2742 | EpiGentek |
|
|
PMS1 Polyclonal Antibody |
|||
A-2744 | EpiGentek |
|
|
SFN Polyclonal Antibody |
|||
A-2745 | EpiGentek |
|
|
SMARCA4 Polyclonal Antibody |
|||
A-2746 | EpiGentek |
|
|
SMARCAL1 Polyclonal Antibody |
|||
A-2747 | EpiGentek |
|
|
SMARCC2 Polyclonal Antibody |
|||
A-2748 | EpiGentek |
|
|
MuERVL-Gag Polyclonal Antibody |
|||
A-2801 | EpiGentek |
|
|
PRMT1 Polyclonal Antibody |
|||
A-3001 | EpiGentek |
|
|
PRMT2 Polyclonal Antibody |
|||
A-3002 | EpiGentek |
|
|
PRMT4 Polyclonal Antibody |
|||
A-3004 | EpiGentek |
|
|
PRMT5 Polyclonal Antibody |
|||
A-3005 | EpiGentek |
|
|
PRMT7 Polyclonal Antibody |
|||
A-3007 | EpiGentek |
|
|
SUV39H2 Polyclonal Antibody |
|||
A-3010 | EpiGentek |
|
|
SET9 Polyclonal Antibody |
|||
A-3014 | EpiGentek |
|
|
CBX4 Polyclonal Antibody |
|||
A-3016 | EpiGentek |
|
|
CBX8 Polyclonal Antibody |
|||
A-3017 | EpiGentek |
|
|
EHMT2 Polyclonal Antibody |
|||
A-3019 | EpiGentek |
|
|
SETDB1 Polyclonal Antibody |
|||
A-3700 | EpiGentek |
|
|
KAT5 Polyclonal Antibody |
|||
A-3701 | EpiGentek |
|
|
SETD1B Polyclonal Antibody |
|||
A-3702 | EpiGentek |
|
|
KDM3B Polyclonal Antibody |
|||
A-3703 | EpiGentek |
|
|
KDM3A Polyclonal Antibody |
|||
A-3704 | EpiGentek |
|
|
Histone H3R2 Dimethyl Symmetric (H3R2me2s) Polyclonal Antibody |
|||
A-3705 | EpiGentek |
|
|
Histone H3R8 Dimethyl Symmetric (H3R8me2s) Polyclonal Antibody |
|||
A-3706 | EpiGentek |
|
|
Histone H3R26 Dimethyl Asymmetric (H3R26me2a) Polyclonal Antibody |
|||
A-3707 | EpiGentek |
|
|
The results allowed us to distinguish the honey honey oak from other types of honey and determine the country of origin. The NMR was a fast and practical method, thus avoiding the need for other more tedious analytical techniques. The first Bulgarian retrospective study of hospitalized patients of COVID-19 was presented. Age, male sex, comorbidity and signs of dyspnea and nausea have been estimated as higher risk factors for a serious form. The anomaly in inflammatory markers was associated with a poor progression of the disease.